Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Toss anything that is more than a few months past its date or shows signs of degradation
-
-20C, 1 month (sealed storage, away from moisture) Publications (15) Journal Impact Factor Most Recent Exp Mol Med Sublytic C5b-9 induces glomerular mesangial cell proliferation via ERK1/2-dependent SOX9 phosphorylation and acetylation by enhancing Cyclin D1 in rat Thy-1 nephritis
In September 2025, the two parties launched Zilebesiran's first phase IV clinical trial
From net deprescription and medication changes alone, cost savings were over $83,000 , or about $1700 per patient per year
Development of New Formulations : Scientists are exploring new formulations of GLP-1 agonists to optimize their delivery and improve patient adherence to treatment regimens
US$ 25.58
US$ 27.04
US$ 28.36
